INTRODUCTION
Hair loss is a common problem that affects women. Greater than 50% of postmenopausal women, with up to 40% of healthy women, experience frontal/parietal hair loss, often beginning around reproductive age.1 The most common type of female hair loss is called androgenetic alopecia (AGA) or female pattern hair loss (FPHL). Other forms of alopecia affecting women include alopecia areata (AA), telogen effluvium (TE), lichen planopilaris (LPP), central centrifugal cicatricial alopecia (CCCA), frontal fibrosing alopecia (FFA), and traction alopecia. Female hair loss can have a psychosocial impact, contributing to a lower self-image, anxiety, and depression.2
Currently, there are a limited number of medications approved by the US Food and Drug Administration (FDA) to address female hair loss. FDA-approved treatments include topical minoxidil for FPHL and 3 oral Janus kinase inhibitors indicated for the treatment of AA.3 With the dearth of options, supplements and nonprescription therapies could play a beneficial role, filling a gap in the management of all females experiencing hair loss.
When discussing the pathophysiology of female hair loss disorders, it is helpful to consolidate etiologies into a few broad categories. These include hormone imbalance, systemic and localized inflammation, nutrient and vitamin deficiencies, aging and cellular senescence, and oxidative stress. Below, we discuss the origins of hair loss and review interventions that may serve as mediators impacting disease progression and reversal.
Hormone Imbalance and Sensitivities Hair loss in women is often influenced by hormonal factors, such as the production of dihydrotestosterone (DHT), polycystic
Currently, there are a limited number of medications approved by the US Food and Drug Administration (FDA) to address female hair loss. FDA-approved treatments include topical minoxidil for FPHL and 3 oral Janus kinase inhibitors indicated for the treatment of AA.3 With the dearth of options, supplements and nonprescription therapies could play a beneficial role, filling a gap in the management of all females experiencing hair loss.
When discussing the pathophysiology of female hair loss disorders, it is helpful to consolidate etiologies into a few broad categories. These include hormone imbalance, systemic and localized inflammation, nutrient and vitamin deficiencies, aging and cellular senescence, and oxidative stress. Below, we discuss the origins of hair loss and review interventions that may serve as mediators impacting disease progression and reversal.
Hormone Imbalance and Sensitivities Hair loss in women is often influenced by hormonal factors, such as the production of dihydrotestosterone (DHT), polycystic